SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000109657-09-000038
Filing Date
2009-12-09
Accepted
2009-12-08 17:36:53
Documents
7
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 OXIS 10-Q Q2 2009 oxis10qq22009.htm 10-Q 680286
2 AMENDMENT TO THE CERTIFICATE OF DESIGNATION FOR THE SERIES G PREFERRED STOCK ex31.htm EX-3.1 7725
3 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex311.htm EX-31.1 13656
4 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex312.htm EX-31.2 13915
5 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex321.htm EX-32.1 6133
6 SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex322.htm EX-32.2 6128
7 OXIS LOGO oxislogo.jpg GRAPHIC 15330
  Complete submission text file 0000109657-09-000038.txt   750744
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 860-5184
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 091229570
SIC: 2834 Pharmaceutical Preparations